ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      56,540.03
      -0.19%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. uniQure NV (QURE)

      7. uniQure NV (QURE) News

      QURE

      uniQure NV (QURE)

      uniQure NV
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:QURE
      DateTimeSourceHeadlineSymbolCompany
      03/01/20234:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      03/01/20234:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      03/01/20234:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      02/27/20235:28PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:QUREuniQure NV
      02/27/20235:00PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      02/27/20234:07PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:QUREuniQure NV
      02/27/20237:21AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:QUREuniQure NV
      02/27/20237:05AMGlobeNewswire Inc.uniQure Announces 2022 Financial Results and Highlights Recent Company ProgressNASDAQ:QUREuniQure NV
      02/23/20238:05AMGlobeNewswire Inc.uniQure Announces HOPE-B Clinical Trial Data Published in the New England Journal of Medicine, Demonstrating Durability and Other Benefits of HEMGENIX® (etranacogene dezaparvovec-drlb)NASDAQ:QUREuniQure NV
      02/23/20238:00AMPR Newswire (US)CSL's HOPE-B Data Published in the New England Journal of Medicine, Demonstrating Efficacy and Durability of HEMGENIX® (etranacogene dezaparvovec-drlb)NASDAQ:QUREuniQure NV
      02/22/20234:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      02/22/20234:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      02/22/20234:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      02/21/20237:05AMGlobeNewswire Inc.uniQure announces the European Commission approval of the first gene therapy for adults with hemophilia BNASDAQ:QUREuniQure NV
      02/14/20235:16PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:QUREuniQure NV
      02/14/20234:35PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:QUREuniQure NV
      02/14/20234:13PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:QUREuniQure NV
      02/09/202312:41PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:QUREuniQure NV
      02/08/20234:35PMEdgar (US Regulatory)Schedule 13g
      (sc 13g/a)      		NASDAQ:QUREuniQure NV
      02/03/20234:37PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:QUREuniQure NV
      01/31/20234:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:QUREuniQure NV
      01/31/20237:05AMGlobeNewswire Inc.uniQure and Apic Bio enter into global licensing agreement for APB-102, a clinical stage gene therapy for patients with ALS caused by mutations in SOD1NASDAQ:QUREuniQure NV
      01/23/20233:57PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:QUREuniQure NV
      12/20/20227:05AMGlobeNewswire Inc.uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:QUREuniQure NV
      12/16/20224:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:QUREuniQure NV
      12/16/20227:15AMGlobeNewswire Inc.uniQure announces positive CHMP opinion for etranacogene dezaparvovec – gene therapy for adults with hemophilia BNASDAQ:QUREuniQure NV
      12/15/20225:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      12/13/20224:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      12/13/20224:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      12/13/20223:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
       Showing the most relevant articles for your search:NASDAQ:QURE